Nothing Special   »   [go: up one dir, main page]

DE602005021110D1 - Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten - Google Patents

Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten

Info

Publication number
DE602005021110D1
DE602005021110D1 DE602005021110T DE602005021110T DE602005021110D1 DE 602005021110 D1 DE602005021110 D1 DE 602005021110D1 DE 602005021110 T DE602005021110 T DE 602005021110T DE 602005021110 T DE602005021110 T DE 602005021110T DE 602005021110 D1 DE602005021110 D1 DE 602005021110D1
Authority
DE
Germany
Prior art keywords
diphenylpyrazole
piperidino
preparing
carboxamide derivatives
carboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005021110T
Other languages
English (en)
Inventor
Marc Daumas
Alain Dlubala
Raphael Sole
Philippe Vayron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Publication of DE602005021110D1 publication Critical patent/DE602005021110D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE602005021110T 2004-07-22 2005-07-20 Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten Active DE602005021110D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0408111A FR2873372B1 (fr) 2004-07-22 2004-07-22 Procede de preparation de derives n-piperidino-1,5- diphenylpyrazole-3-carboxamide
PCT/FR2005/001850 WO2006021652A1 (fr) 2004-07-22 2005-07-20 Procede de preparation de derives n-piperidino-1,5-diphenylpyrazole-3-carboxamide

Publications (1)

Publication Number Publication Date
DE602005021110D1 true DE602005021110D1 (de) 2010-06-17

Family

ID=34949586

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005021110T Active DE602005021110D1 (de) 2004-07-22 2005-07-20 Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten

Country Status (21)

Country Link
US (1) US7462632B2 (de)
EP (1) EP1773783B1 (de)
JP (1) JP4879175B2 (de)
KR (1) KR20070036050A (de)
CN (1) CN100537543C (de)
AR (1) AR049995A1 (de)
AT (1) ATE466843T1 (de)
AU (1) AU2005276350A1 (de)
BR (1) BRPI0510399A (de)
CA (1) CA2564223A1 (de)
DE (1) DE602005021110D1 (de)
FR (1) FR2873372B1 (de)
IL (1) IL179107A0 (de)
MA (1) MA28576B1 (de)
MX (1) MXPA06012954A (de)
NO (1) NO20071008L (de)
RU (1) RU2329252C1 (de)
TW (1) TW200609223A (de)
UY (1) UY29023A1 (de)
WO (1) WO2006021652A1 (de)
ZA (1) ZA200609639B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1816125A1 (de) * 2006-02-02 2007-08-08 Ranbaxy Laboratories, Ltd. Kristalline Formen eines CB1-Cannabinoidrezeptorantagonisten und deren Herstellungsverfahren
WO2008026219A2 (en) * 2006-09-01 2008-03-06 Hetero Drugs Limited Novel polymorphs of rimonabant
WO2008032330A2 (en) * 2006-09-11 2008-03-20 Hetero Drugs Limited Improved process for rimonabant
WO2008035023A1 (en) * 2006-09-19 2008-03-27 Cipla Limited Polymorphs of rimonabant
EP1944297A1 (de) * 2007-01-09 2008-07-16 Miklós Vértessy Festes und kristallines Rimonabant, Herstellungsverfahren dafür und pharmazeutische Zusammensetzung davon
EP1947090A1 (de) * 2007-01-17 2008-07-23 Laboratorios del Dr. Esteve S.A. Verfahren zur Herstellung von N-piperidino-1,5-diphenylpyrazol-3-carboxamid-Derivaten
WO2008088900A2 (en) * 2007-01-18 2008-07-24 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rimonabant base and processes for preparation thereof
US8431609B2 (en) 2007-02-19 2013-04-30 Darmesh Mahendrabhai Shah Process for preparation of pyrazole derivatives
FR2913018A1 (fr) * 2007-02-23 2008-08-29 Sanofi Aventis Sa Solution solide amorphe contenant un derive de pyrazole-3-carboxamide sous forme amorphe et des excipients stabilisateurs
WO2009109222A1 (en) * 2008-03-04 2009-09-11 Maprimed, S. A. Process for the preparation of rimonabant
WO2010079241A1 (es) 2009-01-12 2010-07-15 Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2713225B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2714057B1 (fr) * 1993-12-17 1996-03-08 Sanofi Elf Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
JP4314339B2 (ja) * 2002-08-22 2009-08-12 三井化学アグロ株式会社 ニコチンアミドラゾン誘導体

Also Published As

Publication number Publication date
ATE466843T1 (de) 2010-05-15
MXPA06012954A (es) 2007-02-12
WO2006021652A1 (fr) 2006-03-02
BRPI0510399A (pt) 2007-11-13
KR20070036050A (ko) 2007-04-02
EP1773783B1 (de) 2010-05-05
RU2329252C1 (ru) 2008-07-20
JP4879175B2 (ja) 2012-02-22
AU2005276350A1 (en) 2006-03-02
TW200609223A (en) 2006-03-16
ZA200609639B (en) 2008-08-27
UY29023A1 (es) 2006-02-24
CN100537543C (zh) 2009-09-09
CN1956963A (zh) 2007-05-02
US7462632B2 (en) 2008-12-09
US20080119653A1 (en) 2008-05-22
FR2873372B1 (fr) 2006-09-08
MA28576B1 (fr) 2007-05-02
FR2873372A1 (fr) 2006-01-27
NO20071008L (no) 2007-02-21
CA2564223A1 (fr) 2006-03-02
AR049995A1 (es) 2006-09-20
IL179107A0 (en) 2007-03-08
EP1773783A1 (de) 2007-04-18
JP2008506756A (ja) 2008-03-06

Similar Documents

Publication Publication Date Title
DE502006001614D1 (de) Verfahren zur herstellung von 1-alkyl-3-phenyluracilen
DE502004009763D1 (de) Verfahren zur herstellung von 1-buten
DE502004009768D1 (de) Verfahren zur herstellung von dreiwertigen organophosphor-verbindungen
DE502005010038D1 (de) Verfahren zur herstellung von 3-pentennitril
DE50307672D1 (de) Verfahren zur herstellung von polycarbonaten
ATE516816T1 (de) Verfahren zur herstellung von impfstoffen
ATE408609T1 (de) Verfahren zur herstellung von n-phenylpyrazol-1- carboxamiden
DE602005019848D1 (de) Verfahren zur herstellung von tad- getrocknetem ti
DE602007009096D1 (de) Verfahren zur herstellung von benzopyran-2-olderivaten
DE502006002510D1 (de) Verfahren zur herstellung von silikon-haltigen polymerisaten
ATE444303T1 (de) Verfahren zur herstellung von ferrisuccinylcasein
ATE554088T1 (de) Verfahren zur herstellung von pyridoä2,1- aüisochinolinderivaten
DE60302139D1 (de) Verfahren zur herstellung von aripiprazole
DE502005001841D1 (de) Verfahren zur herstellung von 1,4-diphenylazetidinon-derivaten
DE602005023438D1 (de) Verfahren zur herstellung von polyestern
DE502005003004D1 (de) Verfahren zur herstellung von polycarbonat
DE602005003791D1 (de) Verfahren zur herstellung von 1-(2s,3s)-2-benzhydril-n-(5-tert.-butyl-2-methoxybenzyl)chinuklidin-3-amin
DE602005021110D1 (de) Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten
DE502006002029D1 (de) Verfahren zur herstellung von polyetheraminen
ATE474842T1 (de) Neues verfahren zur herstellung von 5-amino-3h- thiazoloä4,5-düpyrimidin-2-on
DE602006018182D1 (de) Verfahren zur herstellung von aralkyloxypyrrolidinderivaten
DE502005000428D1 (de) Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen
DE602005011814D1 (de) Verfahren zur herstellung von enantiomerreinen 1,1'-spirobiindan-6,6'-diol-derivaten
DE602006008329D1 (de) Verfahren zur herstellung von anilinen
DE502005007702D1 (de) Verfahren zur herstellung von terrylen-3,4:11,12-t

Legal Events

Date Code Title Description
8364 No opposition during term of opposition